6 Result(s)
-
Article
Open AccessAntibiotics-Induced Intestinal Immunomodulation Attenuates Experimental Autoimmune Neuritis (EAN)
The composition of gut microbiota plays a pivotal role in priming the immune system and thus impacts autoimmune diseases. Data on the effects of gut bacteria eradication via systemic antibiotics on immune neur...
-
Article
Open AccessKinesin-5 inhibition improves neural regeneration in experimental autoimmune neuritis
Autoimmune neuropathies can result in long-term disability and incomplete recovery, despite adequate first-line therapy. Kinesin-5 inhibition was shown to accelerate neurite outgrowth in different preclinical ...
-
Article
Open AccessCIDP: Analysis of Immunomarkers During COVID-19 mRNA-Vaccination and IVIg-Immunomodulation: An Exploratory Study
Availability of COVID-19 mRNA vaccine for patients with chronic inflammatory demyelinating polyneuropathy (CIDP) treated with intravenous immunoglobulin (IVIg) raises the question of whether COVID-19 mRNA vac...
-
Article
Open AccessCould symptom overlap of COVID-19 and Guillain–Barré syndrome mask an epidemiological association?
-
Article
Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome
Intravenous immunoglobulins (IVIg) are standard treatment for Guillain-Barré syndrome (GBS). Their exact mechanisms of action are versatile and not fully understood. One possible mechanism is neutralization of...
-
Article
Impact of Age and Polytherapy on Fingolimod Induced Bradycardia: a Preclinical Study
Fingolimod is a an oral disease modifying drug for relapsing remitting multiple sclerosis (MS) preventing egress of B and T cells from lymph nodes. Relevant first dose adverse events include bradycardia and at...
